when were glp 1 drugs approved Indications for GLP-1/GIP RA Summary Sheet and Beyond! Medicare covers GLP-1s for $50/month

It binds to GLP-1 receptorsG proteincoupled receptors widely distributed in pancreatic -cells, gastrointestinal smooth muscle, the central nervous system, heart, kidney, adipose tissue, and reproductive organs

In type 2 diabetes-related cervical cancer tissues, a high-glucose microenvironment induces the upregulation of PSMA2, phosphorylated IB, and phosphorylated P65 expression, thereby promoting tumor progression, while Ex-4 can effectively inhibit this pathological process [120]

March 2026: Novo Nordisk reported top-line REDEFINE-1 Phase 3 CagriSema data showing 22.7% mean body weight reduction at 52 weeks , demonstrating superiority over standalone semaglutide 2.4mg and confirming the semaglutide-plus-amylin combination as clinically competitive with tirzepatide

Professor Receives Grant to Study Effectiveness of GLP-1 Weight-Loss Drugs Andrew Stokes, associate professor of global health, has received a grant from the Robert Wood Johnson Foundation to analyze the real-world effectiveness of this new class of therapies and inequities in access to these medications

Chandel NS

[171] preliminarily showed the excellent efficacy of triple agonists in reversing fatty liver disease in mouse models